108
Participants
Start Date
November 10, 2023
Primary Completion Date
June 6, 2025
Study Completion Date
June 6, 2026
Toripalimab
Toripalimab 240mg administered intravenously on Days 1 of every 3 weeks
Gemcitabine
Gemcitabine 1000 mg/m\^2 administered intravenously on Days 1 \& 8 of every 3 weeks
Nab paclitaxel
Nab paclitaxel 125 mg/m\^2 administered intravenously on Days 1 \& 8 of every 3 weeks.
SBRT
SBRT Radiotherapy plan: Planning gross tumor volume (PGTV) 5Gy\*10 fractions, Planning target volume (PTV) 3Gy\*10 fractions
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing
The First Affiliated Hospital with Nanjing Medical University
OTHER
Fudan University
OTHER
Shanghai Changzheng Hospital
OTHER
The First Affiliated Hospital of Soochow University
OTHER
Xuzhou Central Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER